The awaited quarterly report is due out on Thursday & although it is unlikely to have any earth-shattering news, it is likely to reinforce future expectations by providing some idea of when the approval for all applications could be received.
Usually, following these quarterly reports, there is a surge in buying as investors confidence is enhanced.
Do not expect too much from the report but it should give a clearer picture of what the future has in store.
The 1st May report should see SMN getting closer to having an established future.
What many are forgetting is that, through the Anodyne business, SMN should start to have a positive cash flow & a profit in the vicinity of $2 million per annum. The reporting of this revenue stream should help boost the share price.
- Forums
- ASX - By Stock
- SMN
- Quarterly report due Thursday
Quarterly report due Thursday
Featured News
Add SMN (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.0¢ |
Change
0.010(2.08%) |
Mkt cap ! $72.01M |
Open | High | Low | Value | Volume |
49.0¢ | 49.0¢ | 47.5¢ | $164.4K | 339.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10801 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.0¢ | 20549 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10801 | 0.480 |
1 | 2428 | 0.475 |
2 | 60000 | 0.470 |
2 | 42429 | 0.465 |
3 | 75000 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 20549 | 1 |
0.495 | 19942 | 1 |
0.500 | 68565 | 2 |
0.515 | 13182 | 1 |
0.520 | 94395 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
SMN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online